Publications by authors named "David Warr"

Claim this Profile
R
Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, Canada.
Robert C Grant, Coleman Rotstein, Geoffrey Liu, Leta Forbes, Kathy Vu, David Warr

Support Care Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supportive care in cancer-a MASCC perspective.
Ian Olver, Dorothy Keefe, Jörn Herrstedt, David Warr, Fausto Roila

Support Care Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should palonosetron be a preferred 5-HT receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis.
Ronald Chow, David G Warr, Rudolph M Navari, May Tsao, Marko Popovic

Support Care Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Related Patterns in Cancer Pain and Its Psychosocial Impact: Investigating the Role of Variability in Physical and Mental Health Quality of Life.
Lynn R Gauthier, Robert H Dworkin, David Warr, Rebecca Pillai Riddell, Alison K Macpherson

Pain Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do Correlates of Pain-Related Stoicism and Cautiousness Differ in Younger and Older People With Advanced Cancer?
Kenneth Mah, Kim T Tran, Lynn R Gauthier, Gary Rodin, Camilla Zimmermann, David Warr

J Pain· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-CME information.
Matti Aapro, Mark Clemons, Lee Schwartzberg, David Warr

Support Care Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bringing it all together in the treatment of CINV: application of current knowledge into routine clinical practice.
David Warr

Support Care Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer.
Rossanna C Pezo, Tom W Chen, Hal K Berman, Anna M Mulligan, Albiruni A Razak, David G Warr

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric Evaluation of the Pain Attitudes Questionnaire-Revised for People With Advanced Cancer.
Kenneth Mah, Kim T Tran, Lynn R Gauthier, Gary Rodin, Camilla Zimmermann, David Warr

J Pain· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation options.
Jeremy Lewin, Justin Ming Zheng Ma, Laura Mitchell, Seline Tam, Natasha Puri, David Warr

Support Care Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy.
Jørn Herrstedt, Fausto Roila, David Warr, Luigi Celio, Rudolph M Navari

Support Care Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents.
Karin Jordan, Alexandre Chan, Richard J Gralla, Franziska Jahn, Bernardo Rapoport, David Warr

Support Care Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.
Fausto Roila, David Warr, Paul J Hesketh, Richard Gralla, Jorn Herrstedt

Support Care Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.
Fausto Roila, David Warr, Paul J Hesketh, Richard Gralla, Jorn Herrstedt

Support Care Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysis.
Karin Jordan, David G Warr, Axel Hinke, Linda Sun, Paul J Hesketh

Support Care Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Patient Risk Factors Outperform Antiemetic Guidelines?: Choosing Wisely.
David Warr, Carlo DeAngelis, Edward Chow

JAMA Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aprepitant and fosaprepitant: a 10-year review of efficacy and safety.
Matti Aapro, Alexandra Carides, Bernardo L Rapoport, Hans-Joachim Schmoll, Li Zhang, David Warr

Oncologist· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the short-form McGill pain questionnaire-2 in younger and older people with cancer pain.
Lynn R Gauthier, Alycia Young, Robert H Dworkin, Gary Rodin, Camilla Zimmermann, David Warr

J Pain· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.
Mark J Clemons, Brandy Cochrane, Gregory R Pond, Nadia Califaretti, Stephen K L Chia, David Warr

Breast Cancer Res Treat· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials.
Marko Popovic, David G Warr, Carlo Deangelis, May Tsao, Kelvin K W Chan

Support Care Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for chemotherapy induced nausea and vomiting.
David Warr

Eur J Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The communal coping model and cancer pain: the roles of catastrophizing and attachment style.
Lynn R Gauthier, Gary Rodin, Camilla Zimmermann, David Warr, S Lawrence Librach

J Pain· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of highly emetogenic chemotherapy.
David Warr

Curr Opin Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only).
Fausto Roila, David Warr, Matti Aapro, Rebecca A Clark-Snow, Larry Einhorn

Support Care Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
Louise Bordeleau, Kathleen I Pritchard, Charles L Loprinzi, Marguerite Ennis, Olivera Jugovic, David Warr

J Clin Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis